Some patients report headaches , particularly in the early treatment phase
Tirzepatide and Semaglutide: Impact on Sleep Apnea and Obesity Tirzepatide and Semaglutide for the Treatment of Obstructive Sleep Apnea and Obesity: A Retrospective Analysis OPEN ACCESS PUBLISHED: 31 January 2025 CITATION: Baser, O., Lu, Y., et al., 2025
Self-administration means you control timing and technique
[57] Semaglutide blunts this LPS-induced release of pro-inflammatory cytokines
*Correspondence: Agata Blazewicz, [email protected] Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
That is not a disclaimer bolted onto a sales page it is the actual scope of what is being sold, and it constrains what can honestly be written about it